Serum institute of India came out of left field and was first heard about as a section in the last 4C.
They bought 4 packs of 500 kits of anteobind as part of an experiment looking for better ways to quality test their vaccine.
Discussions took place with SII and it was agreed a 'feasibility study' would be done.
That was last quarter. No news since. We don't know how long the feasibility study is meant to take. We will find out in 2 weeks via the next 4C if SII bought more anteobind.
it was said in the webinar that other vaccine makers are talking to us about similar work.
One of which might be CSL. One of Australia's biggest companies and biggest vaccine maker.
Ann: Investor Briefing, page-215
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.67M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.3¢ | $11.04K | 479.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2941868 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 877838 | 6 |
View Market Depth
| Last trade - 09.59am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.3¢ |
Change
0.000 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.3¢ | 2.3¢ | 247237 | ||
| Last updated 10.04am 30/05/2024 ? | |||||
| ADO (ASX) Chart |